Citadel Advisors’s Global Cord Blood Corporation CO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-10,800
Closed -$32.3K 15794
2023
Q1
$32.3K Hold
10,800
﹤0.01% 12655
2022
Q4
$32.3K Hold
10,800
﹤0.01% 12649
2022
Q3
$32K Sell
10,800
-23,174
-68% -$56.9K ﹤0.01% 11886
2022
Q2
$101K Buy
33,974
+3,471
+11% +$10.8K ﹤0.01% 11409
2022
Q1
$117K Buy
30,503
+799
+3% +$3.32K ﹤0.01% 12119
2021
Q4
$124K Buy
29,704
+2,914
+11% +$12.4K ﹤0.01% 12492
2021
Q3
$125K Sell
26,790
-9,804
-27% -$48.1K ﹤0.01% 12604
2021
Q2
$195K Buy
36,594
+26,567
+265% +$139K ﹤0.01% 12191
2021
Q1
$45K Sell
10,027
-2,275
-18% -$9.87K ﹤0.01% 12945
2020
Q4
$46K Sell
12,302
-26
-0.2% -$100 ﹤0.01% 10596
2020
Q3
$44K Sell
12,328
-13,639
-53% -$47.3K ﹤0.01% 9652
2020
Q2
$80K Buy
25,967
+4,852
+23% +$14.1K ﹤0.01% 9114
2020
Q1
$67K Buy
21,115
+711
+3% +$3.11K ﹤0.01% 8888
2019
Q4
$102K Sell
20,404
-29,735
-59% -$142K ﹤0.01% 8542
2019
Q3
$243K Buy
50,139
+23,603
+89% +$124K ﹤0.01% 7885
2019
Q2
$153K Sell
26,536
-18,327
-41% -$121K ﹤0.01% 8347
2019
Q1
$315K Sell
44,863
-58,524
-57% -$387K ﹤0.01% 7544
2018
Q4
$667K Buy
+103,387
New +$661K ﹤0.01% 5952
2018
Q2
Sell
-88,754
Closed -$905K 9683
2018
Q1
$905K Buy
88,754
+17,771
+25% +$182K ﹤0.01% 4975
2017
Q4
$706K Buy
+70,983
New +$776K ﹤0.01% 5157
2017
Q3
Sell
-21,973
Closed -$208K 8425
2017
Q2
$208K Buy
+21,973
New +$175K ﹤0.01% 6513
2016
Q1
Sell
-21,168
Closed -$135K 8744
2015
Q4
$135K Buy
+21,168
New +$134K ﹤0.01% 6343

Other funds holding CO

Citadel Advisors's CO Position: Q2 2023 in Review

Citadel Advisors sold out of Global Cord Blood Corporation (CO) in Q2 2023, closing a stake of 10,800 shares — an estimated $32.3K sold.

Citadel Advisors first reported a position in CO in Q4 2015 and held it in 22 quarters. The position peaked at $905K in Q1 2018. 6 funds tracked by Wall St. Rank hold CO as of Q2 2023.

  • Citadel Advisors reported no remaining Global Cord Blood Corporation position as of Q2 2023 after selling out during the quarter.
  • Citadel Advisors sold 10,800 Global Cord Blood Corporation shares in Q2 2023, an estimated $32.3K.
  • Citadel Advisors first reported a position in Global Cord Blood Corporation in Q4 2015 and held it in 22 quarters.
  • Citadel Advisors's Global Cord Blood Corporation position peaked at $905K in Q1 2018.
  • 6 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q2 2023.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.